A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Public ClinicalTrials.gov record NCT06807268. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 16-WEEK, MULTICENTER, INTERVENTIONAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ABROCITINIB IN CHILDREN 6 TO LESS THAN 12 YEARS OF AGE WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 years of age who have moderate-to-severe eczema. Research study participants who meet the study criteria will be assigned by chance (like the flip of a coin) to receive either abrocitinib test medicine or placebo (pretend medicine that looks just like the test medicine) for 16 weeks. The study will last for about 24 weeks in total.
Study identification
- NCT ID
- NCT06807268
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 23, 2025
- Primary completion
- May 1, 2027
- Completion
- May 1, 2027
- Last update posted
- Sep 3, 2026
2025 – 2027
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Dermatology & Skin Health Center, LLC | Birmingham | Alabama | 35244 | Recruiting |
| Arkansas Research Trials | North Little Rock | Arkansas | 72117 | Recruiting |
| Investigational Drug Service - Rady Childrens Hospital-San Diego | San Diego | California | 92123 | Recruiting |
| University of California, San Diego/Rady Children's Hospital-San Diego; Pediatric & Adolescent Derm | San Diego | California | 92123 | Recruiting |
| Solutions Through Advanced Research | Jacksonville | Florida | 32256 | Recruiting |
| Ada West Research | Meridian | Idaho | 83646 | Recruiting |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | Recruiting |
| Saint Louis University - Department of Dermatology | St Louis | Missouri | 63104 | Recruiting |
| Medical University of South Carolina - Department of Dermatology | Charleston | South Carolina | 29425 | Recruiting |
| Medical University of South Carolina - South Carolina Translational Research Nexus Clinic | Charleston | South Carolina | 29425 | Recruiting |
| Medical University of South Carolina - Walton Research Building | Charleston | South Carolina | 29425 | Recruiting |
| Tribe Clinical Research, LLC | Greenville | South Carolina | 29607 | Recruiting |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78235 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06807268, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2026 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06807268 live on ClinicalTrials.gov.